Core Laboratories
CLB
365 hedge funds and large institutions have $5.01B invested in Core Laboratories in 2016 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 128 increasing their positions, 126 reducing their positions, and 48 closing their positions.
66% more call options, than puts
Call options by funds: $68.3M | Put options by funds: $41.1M
2% more capital invested
Capital invested by funds: $4.91B → $5.01B (+$95.4M)
2% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 126
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
0.81% less ownership
Funds ownership: 105.42% → 104.6% (-0.81%)
6% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 48
2% less funds holding
Funds holding: 371 → 365 (-6)
Top Buyers
| 1 |
EIP
Epoch Investment Partners
New York
|
+$98.7M |
| 2 |
Bessemer Group
Woodbridge,
New Jersey
|
+$32.7M |
| 3 |
WCM Investment Management
Laguna Beach,
California
|
+$22.6M |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$22.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$22.5M |
Top Sellers
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$72.7M |
| 2 |
WI
WHV Investments
San Francisco,
California
|
-$51.8M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$31.5M |
| 4 |
BAMCO Inc
New York
|
-$25.7M |
| 5 |
Morgan Stanley
New York
|
-$25.2M |
CLB Hedge Fund Activity: Q1 2016 in Review
365 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2016, worth a combined $5.01B — up 1.9% from $4.91B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of CLB and 45 opened new positions — a net loss of 3 holders — while 126 trimmed existing stakes and 128 added.
The largest buyer was Epoch Investment Partners, adding an estimated $98.7M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $72.7M.
- 365 institutional investors held Core Laboratories (CLB) as of Q1 2016, down from 371 in Q4 2015.
- Funds reported $5.01B of Core Laboratories stock for Q1 2016, up 1.9% quarter-over-quarter.
- 45 funds opened new Core Laboratories positions in Q1 2016 and 48 closed out, a net change of -3 holders.
- The largest Core Laboratories buyer in Q1 2016 was Epoch Investment Partners, an estimated $98.7M added.
- The largest Core Laboratories seller in Q1 2016 was Columbia Wanger Asset Management, an estimated $72.7M sold.
Based on aggregated 13F filings for Q1 2016.